<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Biotechs Go Back to the Future by Re-Innovating Old Drugs</title>
	<atom:link href="http://www.xconomy.com/san-diego/2009/08/26/biotechs-go-back-to-the-future-by-re-innovating-old-drugs/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/san-diego/2009/08/26/biotechs-go-back-to-the-future-by-re-innovating-old-drugs/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 09:14:03 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: Best Southern California Surf Spots &#124; Vacations Rental</title>
		<link>http://www.xconomy.com/san-diego/2009/08/26/biotechs-go-back-to-the-future-by-re-innovating-old-drugs/comment-page-1/#comment-99869</link>
		<dc:creator>Best Southern California Surf Spots &#124; Vacations Rental</dc:creator>
		<pubDate>Fri, 18 Dec 2009 15:58:33 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=38300#comment-99869</guid>
		<description>[...] Biotechs Go Back to the Future by Re-Innovating Old Drugs (xconomy.com) [...]</description>
		<content:encoded><![CDATA[<p>[...] Biotechs Go Back to the Future by Re-Innovating Old Drugs (xconomy.com) [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Michael A. Swit</title>
		<link>http://www.xconomy.com/san-diego/2009/08/26/biotechs-go-back-to-the-future-by-re-innovating-old-drugs/comment-page-1/#comment-78534</link>
		<dc:creator>Michael A. Swit</dc:creator>
		<pubDate>Sun, 30 Aug 2009 21:35:35 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=38300#comment-78534</guid>
		<description>Intereesting article.  But, none of this is really news.  These development efforts, especially Avanir and Somaxon, have been in the works for years.</description>
		<content:encoded><![CDATA[<p>Intereesting article.  But, none of this is really news.  These development efforts, especially Avanir and Somaxon, have been in the works for years.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Avnr &#124; Chanel News &#124; News &#124; Breaking News &#124; News Headlines &#124; Latest News &#124; World News &#124; US News &#124; Entertainment News &#124; Daily News &#124; News Channel &#124; Sports News</title>
		<link>http://www.xconomy.com/san-diego/2009/08/26/biotechs-go-back-to-the-future-by-re-innovating-old-drugs/comment-page-1/#comment-78158</link>
		<dc:creator>Avnr &#124; Chanel News &#124; News &#124; Breaking News &#124; News Headlines &#124; Latest News &#124; World News &#124; US News &#124; Entertainment News &#124; Daily News &#124; News Channel &#124; Sports News</dc:creator>
		<pubDate>Sat, 29 Aug 2009 08:12:52 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=38300#comment-78158</guid>
		<description>[...] (AVNR) was catapulted to $4.00 in early August is alone enough to indicate that the &#8230; &#160;  Biotechs Go Back to the Future by Re-Innovating Old DrugsThen there is Avanir Pharmaceuticals (NASDAQ: AVNR), located just across the San Diego border in the [...]</description>
		<content:encoded><![CDATA[<p>[...] (AVNR) was catapulted to $4.00 in early August is alone enough to indicate that the …    Biotechs Go Back to the Future by Re-Innovating Old DrugsThen there is Avanir Pharmaceuticals (NASDAQ: AVNR), located just across the San Diego border in the [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

